Clinical Trial: A phase II study of trastuzumab Rezetecan and carboplatin with or without bevacizumab versus chemotherapy in patients with platinum-sensitive recurrent ovarian cancer (China)

China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A phase II study of trastuzumab Rezetecan and carboplatin with or without bevacizumab versus chemotherapy in patients with platinum-sensitive recurrent ovarian cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133356

Registration Time: 2026/09/24

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center (The Affiliated Tumor Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Institute)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345206

Published by HT Digital Content Services with permission from Health ...